vrinda sharma

Trump signs executive order delaying TikTok ban in US, grants 75-day review period – Moneycontrol

Trump signs executive order delaying TikTok ban in US, grants 75-day review period  Moneycontrol Trump has tossed TikTok a lifeline. But China’s not happy  CNN Donald Trump links TikTok deal to China tariffs; will Beijing approve the sale to US?  The Economic Times TikTok Ban Live Updates: Trump Halts Ban For 75 Days—After CEO Attends Inauguration  Forbes Trump signs…

Read More

Pushpa 2 Hindi Box Office Collection (47 Days): Allu Arjun’s Monster Blockbuster Rakes In 316% Returns! – Koimoi

Pushpa 2 Hindi Box Office Collection (47 Days): Allu Arjun’s Monster Blockbuster Rakes In 316% Returns!  Koimoi Pushpa 2 box office collection day 47: The Allu Arjun starrer begins to lose steam now as it records its  TOI Etimes Pushpa 2 box office collection day 48: Allu Arjun, Rashmika Mandanna film stays steady, earns Rs…  DNA India Pushpa…

Read More

US secretary of state Rubio to hold first bilateral meeting with EAM Jaishankar – The Times of India

US secretary of state Rubio to hold first bilateral meeting with EAM Jaishankar  The Times of India US secretary of state Marco Rubio to hold first bilateral meeting with EAM Jaishankar  Hindustan Times ‘Great Honour’: S Jaishankar In Front Row Seat At Trump Inauguration  NDTV EAM Jaishankar Takes Front Seat At Trumps Swearing-In Event Signifying Importance Of India-US…

Read More
Not just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says groundbreaking study

Not just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says groundbreaking study

A discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond their primary uses. This includes unexpected benefits such as aiding in blood clotting and infections, and treating Alzheimer’s, heart conditions, and mental health issues. A discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively…

Read More